Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
ABSTRACTThe immunogenicity and safety of the concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine (Split Virion) (QIIV) in Chinese adults are unclear. In this open-label, randomized controlled trial, participants aged ≥ 18 years were recruited. El...
| मुख्य लेखकों: | , , , , , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | English |
| प्रकाशित: |
Taylor & Francis Group
2024-12-01
|
| श्रृंखला: | Human Vaccines & Immunotherapeutics |
| विषय: | |
| ऑनलाइन पहुंच: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2330770 |